Both in Pharmaceuticals
PepGen vs BridgeBio Oncology Therapeutics
Over the past year PEPG returned −45.9% and BBOT returned −81.0%; their daily moves had a correlation of 0.11.
PEPG −45.9% BBOT −81.0%Growth of $1, one year, split-adjusted
| Metric | PEPG | BBOT |
|---|---|---|
| Price | $2.45 | $2.30 |
| Market cap | $169.7M | $184.4M |
| Today | −0.41% | −0.86% |
| 1 month | +6.1% | −34.3% |
| 6 months | +32.8% | −72.4% |
| Year to date | −62.4% | −81.6% |
| 1 year | −45.9% | −81.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $117.2M | $225.7M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 87.9% |
| Short % of float | 9.6% | 13.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).